Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

Bullboard (GREY:CTABF)

View:
Post by Betteryear2on Dec 02, 2021 11:45am

Agreement with Pathway Health

TORONTO, Dec. 2, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the ...more  
Comment by Druchiion Nov 11, 2021 6:11pm

RE:RE:Huge News

I hear you, I was expecting much more as well. Took the opportunity to buy more.  Not sure why anyone would sell on this news for a few pennies.  This was the announcement all shareholders ...more  
Comment by Eppyon Nov 11, 2021 5:04pm

RE:Huge News

I agree that it is huge news.  I have to admit though, I am a little disappointed that the share price only went up  10 cents.  I am sure more news is coming over the next few weeks and ...more  
Post by Druchiion Nov 11, 2021 9:44am

Huge News

This news is huge - amazing job Canntab! Company has low market cap and is the only producer with Cannabis 3.0. Seems like a multi-bagger from here!!
Comment by Eppyon Nov 11, 2021 9:40am

RE:Halt?

News is out. Last approval given. The company can now concentrate on production and sales.
Post by Bullrunon Nov 10, 2021 5:23pm

Halt?

ANYONE?
Post by Druchiion Nov 01, 2021 3:54pm

OCS Stores

Anyone know if we can expect Canntab's products to hit OCS stores in the near future?
Post by Druchiion Oct 18, 2021 4:16pm

Looks very promising

Liking the distribution deal announced today + recent insider purchases... Market cap only $25MM > seems very cheap relative the opportunity
Post by KandiBirdBoyon May 10, 2021 10:51am

✨ GOLD PROXY ONLY $HUGE FSD PHARMA SHAREHOLDERS VS CEO 🏆

Change is Needed Now Dr. Raza Bokhari, FSD’s Chief Executive Officer, and his hand picked board members have: failed to address the dramatic loss of ...more  
Comment by Eppyon Feb 01, 2021 10:17am

RE:Any competitors?

Druchi:  Check out the company's NR put out this morning.  It will give you some more insight into this company. GLTA.
Post by Druchiion Jan 25, 2021 9:45pm

Any competitors?

Does seem logical that a hard pill is the best THC delivery system for the reasons outlined in the investor presentation.  Does any other company make hard pills?
Comment by Chuckytooluckyon Jan 23, 2021 7:43am

RE:RE:Any news??

have hopes that pill will fly up and away. Lambourgini money this year? 
Comment by fromBelgienon Jul 21, 2020 2:33pm

RE:Any news??

this year will be the year of Canntab ! When will this start up????
Comment by stealthcton Jun 09, 2020 2:45pm

RE:Halt

going down to 50 cents.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities